品牌:NIBSC
起订:1mg
供应:100mg
发货:7天内
信息标签:NIBSC代理1,供应,化工,生物化工
00/416 Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
00/418 MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)
00/422 High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
00/440 Influenza anti A/Singapore/1/57 Serum (sheep) H2
00/442 Influenza anti B/Yamanashi/166/98 Serum (sheep)
00/464 Streptokinase (3rd International Standard 2001)
00/500 Botulinum Antitoxin Human
00/530 Influenza Virus infectious B/Sichuan/379/99
00/542 Influenza anti A/Chick/Scotland/59 (H5N1) Serum (sheep)
00/544 Influenza Virus infectious B/Victoria/504/00
00/546 Influenza Antigen B/Johannesburg/5/99
00/552 Influenza Antigen A/duck/Singapore/97 (H5N3)
00/556 Influenza anti B/Johannesburg/5/99/ Serum (sheep)
00/562 Hepatitis A Virus for Nucleic Acid Amplification Techniques(2nd International Standard)
00/572 Interferon Beta (Human, rDNA; CHO cell-derived; Glycosylated)(3rd International standard)
00/574 Interferon Beta Ser 17 Human, recDNA, E-coli-derived, non-glycosylated
00/576 Interferon Beta, Human, Fibroblast Cell-Derived, Glycosylated
00/614 Influenza Virus infectious B/Guangdong/120/00
007SP Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)
01/412 Anti-Meningococcal immunotype L3,7,9 mAb
01/420 Interleukin-17 Human rec DNA(International Reference Reagent)
01/424 Vascular Endothelial Growth Factor, Human rDNA derived
01/426 Meningococcal group Y polysaccharide
01/428 Meningococcal group W135 polysaccharide
01/450 Influenza anti B/Guangdong/120/2000 Serum (sheep)
01/452 Influenza anti A/Panama/2007/99 Serum (sheep)
01/506 Botulinum Antitoxin Equine Type F
01/508 Botulinum Antitoxin Equine Type C
01/510 Botulinum Antitoxin Equine Type D
01/512 Botulinum Antitoxin Equine Type G
01/514 Anti-Meningococcal Serosubtype P1.7 mAb
01/528 Oral Poliovaccine Sabin Reference Preparation Type 1[LS-c, 2ab strain] (Panel of 5 ampoules)
01/530 Oral Poliovaccine Sabin Reference Preparation Type 2 (Panel of 5 ampoules)
01/532 Oral Poliovaccine Sabin Reference Preparation Type 3 (Panel of 5 ampoules)
01/538 Anti-Meningococcal Serosubtype P1.16 mAb
01/546 Influenza Antigen B/Guangdong/120/2000
01/572 Anti-D Immunoglobulin(International Standard)
01/580 Thrombin, human(2nd International Standard)
01/600 Anti-Toxoplasma IgG, Human(International Standard)
01/602 Anti-Parvovirus B19, plasma, human(2nd International Standard)
01/612 Influenza Virus infectious B/Hawaii/10/01
01/614 Influenza Antigen A/New Caledonia/20/99
02/102 Influenza anti A/Panama/2007/99 Serum (sheep)
02/144 Anti-Meningococcal Serosubtype P1.15 mAb
02/148 Anti-Meningococcal Serosubtype P1.4 mAb
02/168 Prekallikrein Activator (PKA), Human(2nd International Standard)
02/176 Diphtheria Toxoid for use in Flocculation Test(2nd International Standard)
02/178 Anti-Meningococcal Serosubtype P1.2 mAb
02/180 Anti-Meningococcal Serotype P2.2a mAb
02/182 Anti-Japanese Encephalitis Virus Plasma, Human
02/184 Anti-Japanese Encephalitis (Anti-JE) Virus Control Plasma, Human
02/186 Anti-Dengue Virus Types 1+2+3+4, Human(Intrnational Reference Reagent)
02/206 Blood Coagulation Factor XIII, Plasma, Human (1st International Standard)
02/210 HIV (antibody), 1st International Reference Panel
02/226 IVIG negative control for use with IVIG + anti-D(International Reference Reagent)
02/228 IVIG + anti-D for use with negative control IVIG(International Reference Reagent)
02/230 Biotinylated Brad-5
02/232 Tetanus Toxoid Not Adsorbed
02/254 Insulin-like growth Factor I(1st International Standard)
02/262 Influenza Virus infectious B/Brisbane/32/2002
02/286 Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(International Reference Reagent)
02/294 Influenza Antiserum A/chick/Italy/1347/99 (H7N1)
02/306 Polio Virus Sabin Types 1, 2 and 3(2nd International Reference Reagent)
02/308 Anti-Meningococcal Serotype P3.4 mAb
02/310 Anti-Meningococcal Serotype P3.15 mAb
02/318 Botulinum Antitoxin Equine Type E
02/320 Anti-Meningococcal Serosubtype P1.3 mAb
02/336 Influenza Antigen A/New Caledonia/20/99
02/338 Influenza anti A/Panama/2007/99 Serum (sheep)
02/342 Protein C Plasma, Human(2nd International Standard)
03/104-014 HTLV-1 (antibody) Monitor Sample
03/110 Influenza anti B/Shangdong/9/97 Serum (sheep)
03/114 Anti-Meningococcal Serosubtype P1.1 mAb
03/116 Blood Coagulation Factor V, Plasma(1st International Standard)
03/124 Thrombopoietin, human rDNA derived
03/142 Anti-Meningococcal Serosubtype P1.14 mAb
03/148 Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st International Reference Reagent)
03/150 Keratinocyte Growth Factor (KGF,FGF-7)(1st International Reference Reagent)
03/152 Anti-HPA-1a (International Standard)
03/164 Anti-B minimum potency reference preparation(International Standard)
03/178 Vitamin B12, Serum Folate(International standard)
03/182 Anti-Meningococcal Serotype P3.21 mAb
03/188 Anti-A minimum potency reference preparation(International Standard)
03/190 Anti-HPA-3a(minimum potency)(International Reference Reagent)
03/192 Thyroid Stimulating Hormone, recombinant(1st International standard)
03/198 Influenza Virus infectious A/Kumamoto/102/02
03/200 Interleukin - 18 (Human rDNA derived)(International Referennce Reagent)
03/210 Anti-Meningiococcal Serosubtype P1.6 mAb
03/212 Influenza anti A/Wyoming/03/03 Serum
03/220 Influenza Antigen A/Wyoming/03/03
03/224 Anti-Meningococcal Serosubtype P1.10 mAb
03/226 Anti-Meningococcal Serosubtype P1.5 mAb
03/228 Protein S, Plasma, Human(2nd International Standard)
03/236 Anti-Meningococcal Serosubtype P1.13 mAb
03/242 Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum
03/244 Influenza anti A/chick/Germany/N/49 (H10N7) HA Serum (sheep)
03/258 Influenza Antigen A/New Caledonia/20/99 (IVR-116)
03/262 Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)
04/102 Blood Coagulation Factor XI Plasma, Human(1st International Standard)
04/122 Anti-Meningococcal Serosubtype P1.12 mAb
04/132 IVIG + Anti-D for use with negative control IVIG
04/140 IVIG Negative Control for use with IVIG & Anti-D
04/150 Tetanus Toxoid For Flocculation Test(2nd International Standard)
04/160 Influenza Virus infectious NYMC X-147
04/166 TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st International Reference Reagent)
04/170 Influenza Virus infectious A/Wellington/1/2004
04/172 Influenza Virus infectious IVR-139
04/176 Plasmodium falciparum DNA for NAT Assays(1st International Standard)
04/198 Anti-Meningococcal Serotype P3.1 mAb
04/200 Parathyroid hormone 1-34 ,Recombinant, Human(International Standard)
04/202 Influenza Antigen B/ Jiangsu/10/2003
04/214 Influenza anti A/Vietnam/1194/04 (NIBRG-14) HA Serum (sheep SH440&SH442)
04/224 Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004
04/228 Influenza anti B/ Neuraminidase Serum
04/230 Influenza anti N1 Neuraminidase Serum
04/242 Influenza anti B/Jiangsu/10/2003 HA Serum (sheep)
04/246 Anti-Meningococcal Serogroup W-135 mAb
04/248 Anti-Meningococcal Serosubtype P1.19 mAb
04/252 Protein C Concentrate, Human(1st International Standard)
04/258 Influenza anti N2 Neuraminidase Serum(prepared from A/Wyoming/3/2003)
04/260 Influenza anti A/New Caledonia/20/99 HA Serum (sheep)
04/262 Influenza anti A/New York/55/2004 HA Serum (sheep)
04/264 Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)
05/102 Influenza Virus infectious NYMC BX-7
05/106 Anti-HPA-1a minimum potency reagent(2nd International Reference reagent)
05/110 Influenza Virus infectious A/California/7/2004
05/112 Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).
05/122 Anti-syphilis plasma IgG (human)(1st International Standard)
05/130 Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)
05/132 Anti-syphilis plasma IgG and IgM (human)(1st International Standard)
05/134 Anti-human papillomavirus type 16 serum (1st International Standard)
05/138 Influenza Virus infectious B/Shanghai/361/2002
05/162 Alpha-1-Antitrypsin, plasma derived(1st International standard)
05/190 Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody
05/192 Anti Meningococcal Serotype P2.2b Monoclonal Antibody
05/232 Influenza Virus infectious A/Hiroshima/52/2005
05/234 Influenza Antigen A/Wisconsin/67/2005 - Like
05/236 Influenza anti A/Wisconsin/67/2005 Serum (sheep)
05/242 IVIG, Anti-D and Negative Control Panel
05/248 Anti Dengue, WHO Reference Panel
05/252 Influenza anti B Neuraminidase Serum (Sheep SH463)
06/102 Hepatitis C Virus for Nucleic Acid Amplification Techniques (4th WHO International Standard)
06/108 Influenza Virus infectious IVR-116
06/114 Influenza Virus Infectious A/PR/8/34
06/124 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard)
06/128 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard)
06/140 Pertussis Antiserum(human)1st IS-WHO international Standard.
06/142 Pertussis Antiserum (Human) 1st WHO Reference Reagent
06/164 Influenza Virus infectious 1 VR-142
06/166 Antithrombin Concentrate, Human (3rd International Standard)
06/170 Influenza Antigen A/New Caledonia/20/99
06/172 FEIBA Concentrate 1st NIBSC Working Reference Standard
06/192 Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)
06/202 HPV Type 16 DNA (1st International Standard)
06/206 HPV Type 18 DNA (1st International Standard)
06/210 Medium Titre Meningococcal OMV Ref. serum
06/236 Influenza Virus infectious A/Solomon Islands/3/2006 07/132
06/242 Influenza Virus infectious NYMC-X161 B
06/B461-08 QCRHIV1QC5-Anti-HIV1: Quality Control Serum: Sample5
07/102 Influenza Antigen A/Solomon Islands/3/2006 (IVR-145)(H1N1)
07/104 Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum (sheep 467,468,469,470)
07/112 Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23
07/132 Influenza Virus infectious B/Malaysia/2506/2004
07/144 Influenza Virus infectious IVR-145,
07/146 Influenza anti A/HongKong/1073/99 like HA Serum (sheep)
07/148 Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum
07/150 Human Plasma Anti-Influenza H5N1 (1st International Standard)
07/162 Rabies vaccine (6th International Standard)
07/164 Anti-HBs immunoglobulin (2nd International Standard)
07/182 Blood Coagulation Factor IX Concentrate, Human, 4th International Standard”
07/184 Influenza anti B/Malaysia/2506/2004-HA Serum (sheep)
07/202 Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)
07/214 Positive Control for use in flow cytometry cross matching (FCXM) and anti-HLA serology
07/216 Diphtheria Toxoid (Adsorbed) (4th International Standard)
07/222 RhD/SRY Plasma DNA sensitivity standard(1st International Reference Reagent)
07/226 Influenza Virus Infectious A/New Caledonia/20/99
07/228 Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”
07/246 Influenza Virus Infectious IVR-147
07/268 Influenza Virus Infectious B/Brisbane/3/2007
07/270 BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)
07/272 BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)
07/274 BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)
07/278 Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)
07/286-012 Hepatitis B Surface Antigen Monitor Sample
07/288-011 Hepatitis B Surface Antigen 0.2IU/ml
07/290 Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6
07/294-005 Norovirus GII for Nucleic Acid Amplification Techniques
07/298-004 Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques
07/300-004 Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques
07/304 Anti-D for assuring operator and test performance
07/306 Anti-A and Anti-B in IVIG Positive Control( International Reference Reagent)
07/308 Anti-A and Anti-B in IVIG Negative Control (International Reference Reagent)
07/310 Anti-A and anti-B in IVIG: Limit reference preparation(International Reference Reagent)
07/316 Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)
07/318 Meningococcal Group C Polysaccharide
07/326 Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard.
07/328 Unfractionated Heparin (6th I.S.)
07/336 Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60
07/338 Influenza anti A/Anhui/1/05 (H5)HA serum (IBCDC-RG6) (Sheep SH477)
07/348 Influenza Virus infectious NYMC X-171B
07/350 Blood Coagulation Factor VIII Concentrate (8th I.S.)
07/358 Influenza Virus infectious NIB-50
07/362 Influenza Virus infectious IVR-149
07/364 Chorionic Gonadotrophin, (5th International Standard)
07/B498-15 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1
07/B498-16 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1
07/B512-14 QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2